Company / Shares Outstanding
Astria Therapeutics, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
56.2M
FY2024
5-year range
3.1M / 56.2M
FY2020-FY2024
Trend
+86.4%
vs FY2023
Sector context
#153 of 212
Health Care
What the data says
At 56161249.00, Astria Therapeutics, Inc.'s shares outstanding ranks #60 of 212 in the Health Care sector. Shares Outstanding has increased for 4 consecutive years, from 3058578.00 in FY2020 to 56161249.00 in FY2024.
Based on SEC 10-K filings.
56161249.00 in FY2024 with a 5-year CAGR of +42.1%.
Increased from 14620618.00 to 56161249.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +84.6%
- 5-Year CAGR
- +42.1%
- 10-Year CAGR
- -
Sector benchmark
#60 of 212 in Health CareTop 28% of 212This company 56.2M Sector average 306.7M
▼
-81.7% below sector average
Key checks
Key Insights
- Astria Therapeutics, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2024, shares outstanding increased 86.4% year-over-year.
- Ranks #153 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 56.2M | +86.4% |
| FY2023 | 30.1M | +106.0% |
| FY2022 | 14.6M | +63.8% |
| FY2021 | 8.9M | +191.8% |
| FY2020 | 3.1M | -68.4% |
| FY2019 | 9.7M | +91.6% |
| FY2018 | 5.1M | +133.1% |
| FY2017 | 2.2M | -86.6% |
| FY2016 | 16.2M | +101.8% |
| FY2015 | 8.0M | +1794.6% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026